Skip to Main Content

An official website of the United States government

Here you can browse the complete list of publications for studies listed on CDAS.

Publication Year
Title PubMed Authors Journal Year Studies
Design and evolution of the data management systems in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. 11189686 Hasson MA, Fagerstrom RM, Kahane DC, Walsh JH, Myers MH, Caughman C, Wenzel B, Haralson JC, Flickinger LM, Turner LM, Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team Control Clin Trials 2000 PLCO
The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. 11189683 Gohagan JK, Prorok PC, Hayes RB, Kramer BS, Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team Control Clin Trials 2000 PLCO
Quality control of cancer screening examination procedures in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. 11189690 Weissfeld JL, Fagerstrom RM, O'Brien B, Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team Control Clin Trials 2000 PLCO
The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Gohagan JK Control Clin Trials 2000 PLCO
Helical CT colonography (virtual colonoscopy): the challenge that exists between advancing technology and generalizability. 10470878 McFarland EG, Brink JA AJR Am J Roentgenol 1999 PLCO
Rationale for randomised trials of prostate cancer screening. The International Prostate Screening Trial Evaluation Group. 10448269 Eur. J. Cancer 1999
Participation in breast cancer risk counseling among women with a family history. 10428194 Bowen D, McTiernan A, Burke W, Powers D, Pruski J, Durfy S, Gralow J, Malone K Cancer Epidemiol Biomarkers Prev 1999 PLCO
Recruiting black men to a clinical trial to evaluate prostate cancer screening--Detroit, Michigan, 1998. 9733417 Centers for Disease Control and Prevention (CDC) MMWR Morb. Mortal. Wkly. Rep. 1998 PLCO
Periodic screening for breast cancer: the HIP Randomized Controlled Trial. Health Insurance Plan. 9709271 Shapiro S J. Natl. Cancer Inst. Monographs 1997 HIPB
Prospective evaluation plan for randomised trials of prostate cancer screening. The International Prostate Cancer Screening Trial Evaluation Group. 8849769 Auvinen A, Rietbergen JB, Denis LJ, Schröder FH, Prorok PC J Med Screen 1996
Screening and prevention trials step up minority recruitment. 8797765 Reynolds T J. Natl. Cancer Inst. 1996 PLCO
The Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial of the National Cancer Institute. Gohagan JK, Prorok PC, Kramer BS, Hayes RB, Cornett JE Cancer 1995 PLCO
Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute. 7523735 Gohagan JK, Prorok PC, Kramer BS, Cornett JE J. Urol. 1994 PLCO
"Screening for prostate cancer". 7528519 Gohagan JK, Kramer BS, Greenwald P Am J Prev Med 1994
NIH Consensus 1994: screening. 7835804 Kramer BS, Gohagan J, Prorok PC Gynecol. Oncol. 1994 PLCO
The National Cancer Institute multi-screening trial. Prorok PC, Gohagan J, Kramer B Canadian J Urol 1994 PLCO
The National Cancer Institute Multi-Screening Trial. 8853500 Prorok P Can J Oncol 1994 NLST
A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers. 8420681 Kramer BS, Gohagan J, Prorok PC, Smart C Cancer 1993 PLCO
Prostate cancer screening: what we know and what we need to know. 7692780 Kramer BS, Brown ML, Prorok PC, Potosky AL, Gohagan JK Ann. Intern. Med. 1993 PLCO
Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. 8474513 Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F N Engl J Med 1993 MINN